| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199410 | Ophthalmology | 2016 | 5 Pages |
Abstract
Continued once-per-day use of a topical corticosteroid, even a weak one, was protective against rejection episodes during the second year after DMEK, whereas 6% experienced a rejection episode when steroids were discontinued. Among the 364 eyes that completed 12 months' follow-up, only 1 graft (0.27%) failed.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Marianne O. PhD, Amanda BS, Matthew T. MD, Francis W. MD,